Skip Navigation LinksHome > June 2001 - Volume 28 - Issue 6 > Effect of Chlamydia trachomatis Coinfection on HIV Shedding...
Sexually Transmitted Diseases:
Letter to the Editor

Effect of Chlamydia trachomatis Coinfection on HIV Shedding in Genital Tract Secretions

KILMARX, PETER H. MD*†; MOCK, PHILIP A. MAppStat* AND; LEVINE, WILLIAM C. MD, MSc†

Free Access
Article Outline
Collapse Box

Author Information

From the *HIV/AIDS Collaboration, Nonthaburi, Thailand; and the †Division of STD Prevention, National Center for HIV, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia

Correspondence: Peter H. Kilmarx, MD, The HIV/AIDS Collaboration, DMS 6 Building, Ministry of Public Health, Tivanon Road, Nonthaburi 11000, Thailand. E-mail: pbk4@cdc.gov

Received for publication September 25, 2000, and accepted November 16, 2000.

To the Editor:

The relations between HIV infection and other sexually transmitted diseases (STDs) are complex. 1 Some studies show that other STDs may enhance HIV infectiousness in men and women by increasing viral shedding in genital tract secretions. In their review, Rotchford et al. 2 combined data from four studies and concluded that HIV was not detected significantly more frequently in the genital secretions of HIV-infected persons with Chlamydia trachomatis infection than in the secretions of those without HIV. This report seeks to underscore and expand on the authors’ caveats, including problems in choosing appropriate comparison groups, gender of the participants, and methods for detecting chlamydia and HIV.

One of the four Rotchford et al. 2 studies assessed 106 men who, as specified by the study protocol, had dysuria, urethral discharge, or genital ulceration. 3 The nine men in the study who had nongonococcal urethritis were somewhat less likely than those without the disorder to be shedding HIV. However, the current authors believe this study should not be included in an analysis of chlamydial infection and HIV shedding because everyone in the comparison group had other STD syndromes, also potentially making them more likely to be shedding HIV. For instance, 73% of the men in the comparison group had gonorrhea, and those with gonorrhea accounted for 83% of those who were shedding HIV. Furthermore, in that particular study, specific chlamydial testing was not performed, so it should not be used to address the issue of chlamydial infection and HIV shedding.

Each of the remaining three studies involved women. The largest of these studies showed that female sex workers with chlamydial infection were three times more likely to be shedding HIV than those without chlamydia. 4 In the other two studies, HIV shedding was also somewhat more commonly detected among women with chlamydial infection than among those without chlamydia, although these differences were not statistically significant. 5,6 However, the results pooled from these three studies showed that chlamydial infection was significantly associated with HIV shedding (Mantel-Haenszel odds ratio, 1.85; 95% CI, 1.1–3.2;P = 0.02). There was not substantial heterogeneity in the results from these three studies (Breslow-Day test for heterogeneity, P = 0.3), but meta-analysis may not be appropriate because of differences in study populations and methods.

The current authors agree with the call of Rotchford et al 2 for additional high-quality studies to address this issue. In the meantime, screening, treatment, and prevention of STDs, including chlamydial infection, remain an important part of care for HIV-infected persons. 7

PETER H. KILMARX, MD*†

PHILIP A. MOCK, MAppStat* AND

WILLIAM C. LEVINE, MD, MSc†

Back to Top | Article Outline

References

1. Fleming DT, Wasserheit JN. From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sex Transm Infect 1999; 75: 3–17.

2. Rotchford K, Strum AW, Wilkinson D. Effect of coinfection with STDs and of STD treatment on HIV shedding in genital tract secretions. Sex Transm Dis 2000; 27: 243–248.

3. Moss GB, Overbaugh J, Welch M, et al. Human immunodeficiency virus DNA in urethral secretions in men: association with gonococcal urethritis and CD4 depletion. J Infect Dis 1995; 172: 1469–1474.

4. Ghys PD, Fransen K, Diallo M, et al. The associations between cervicovaginal HIV shedding, sexually transmitted diseases, and immunosuppression in female sex workers in Abidjan, Côte d’Ivoire. AIDS 1997; 11: F85–F93.

5. John GC, Nduati RW, Mbori-Ngacha D, et al. Genital shedding of human immunodeficiency virus type 1 DNA during pregnancy: association with immunosuppression, abnormal cervical or vaginal discharge, and severe vitamin A deficiency. J Infect Dis 1997; 175: 57–62.

6. Mostad SB, Overbaugh J, DeVange DM, et al. Hormonal contraception, vitamin A deficiency, and other risk factors for shedding of HIV-1 infected cells from the cervix and vagina. Lancet 1997; 350: 922–927.

7. Centers for Disease Control and Prevention. HIV prevention through early detection and treatment of other sexually transmitted diseases: United States recommendations of the advisory committee for HIV and STD prevention. MMWR Morb Mortal Wkly Rep 1998; 47: 1–24.

Cited By:

This article has been cited 9 time(s).

AIDS Research and Human Retroviruses
Association of Cervical Biopsy with HIV Type 1 Genital Shedding Among Women on Highly Active Antiretroviral Therapy
Woo, VG; Liegler, T; Cohen, CR; Sawaya, GF; Smith-McCune, K; Bukusi, EA; Huchko, MJ
AIDS Research and Human Retroviruses, 29(7): 1000-1005.
10.1089/aid.2012.0341
CrossRef
Current Hiv Research
Measuring the infectiousness of persons with HIV-1: Opportunities for preventing sexual HIV-1 transmission
Baeten, JM; Overbaugh, J
Current Hiv Research, 1(1): 69-86.

Current Opinion in Molecular Therapeutics
Developing effective delivery systems for Chlamydia vaccines
Igietseme, JU; Eko, FO; He, Q; Bandea, C; Black, CM
Current Opinion in Molecular Therapeutics, 6(2): 182-194.

Obstetrics and Gynecology
Histologic endometritis in asymptomatic human immunodeficiency virus-infected women: Characterization and effect of antimicrobial therapy
Eckert, LO; Watts, DH; Thwin, SS; Kiviat, N; Agnew, KJ; Eschenbach, DA
Obstetrics and Gynecology, 102(5): 962-969.
10.1016/S0029-7844(03)00857-3
CrossRef
Journal of Infectious Diseases
Role of T Lymphocytes in the Pathogenesis of Chlamydia Disease
Igietseme, JU; He, Q; Joseph, K; Eko, FO; Lyn, D; Ananaba, G; Campbell, A; Bandea, C; Black, CM
Journal of Infectious Diseases, 200(6): 926-934.
10.1086/605411
CrossRef
Science in China Series C-Life Sciences
Immunization with chlamydial plasmid protein pORF5 DNA vaccine induces protective immunity against genital chlamydial infection in mice
Li, ZY; Wang, SP; Wu, YM; Zhong, GM; Chen, D
Science in China Series C-Life Sciences, 51(): 973-980.
10.1007/s11427-008-0130-9
CrossRef
Biomedical and Environmental Sciences
Development of ELISAs for the Detection of Urogenital Chlamydia trachomatis Infection Targeting the pORF5 Protein
Li, ZY; Huang, QL; Su, SM; Zhong, GM; Wu, YM
Biomedical and Environmental Sciences, 26(3): 169-175.
10.3967/0895-3988.2013.03.003
CrossRef
AIDS
Recent observations on HIV type-1 infection in the genital tract of men and women
Coombs, RW; Reichelderfer, PS; Landay, AL
AIDS, 17(4): 455-480.

PDF (919)
Sexually Transmitted Diseases
The Effect of Genital Tract Infections on HIV-1 Shedding in the Genital Tract: A Systematic Review and Meta-Analysis
Johnson, LF; Lewis, DA
Sexually Transmitted Diseases, 35(11): 946-959.
10.1097/OLQ.0b013e3181812d15
PDF (743) | CrossRef
Back to Top | Article Outline

© Copyright 2001 American Sexually Transmitted Diseases Association

Login